Medical Devices Group

  • Community
  • Webinars
  • Jobs
  • Events
  • Contact
  • Go Premium
« Back to Previous Page
Marcus Gould
Senior Regulatory Affairs Consultant at ConvaTec
October 2015
Medical device regulation update
< 1 min reading time

For us who work in the medical device regulatory world we are aware that the current regulation governing the affixing of the CE mark is going through a significant revision. This process is slowly, but surely, coming to an end and we are already seeing, and experiencing, the changes.

It can be difficult keeping on top of the amendments as they go through the political process, however the consolidated text of both the proposed Medical Device Regulation and the In Vitro Diagnostic Regulation which have been prepared by the Luxembourg Presidency (the current holders of the Presidency of the Council of the European Union) has just been released.

They are a detailed read and, of course, these are not the finalised text, however they do give some indication of the changes and additions that shall be finally implemented.

For the revised consolidated text of the recitals and articles of the proposed Regulation on medical devices, go to:

http://data.consilium.europa.eu/doc/document/ST-12040-2015-REV-1/en/pdf

For the consolidated text of the annexes to the proposed Regulation on medical devices, go to:

http://data.consilium.europa.eu/doc/document/ST-12040-2015-ADD-1/en/pdf

For the consolidated text of the recitals and articles of the proposed Regulation on in vitro diagnostic medical devices, go to:

http://data.consilium.europa.eu/doc/document/ST-12042-2015-INIT/en/pdf

For the consolidated text of the annexes to the proposed Regulation on in vitro diagnostic medical devices, go to:

http://data.consilium.europa.eu/doc/document/ST-12042-2015-ADD-1/en/pdf

Happy reading, and don’t forget, its never too early to identify the changes which affect your activities, processes and procedures!

source: https://www.linkedin.com/groups/78665/78665-6055806684582993923

Marked as spam
Posted by Marcus Gould
Asked on October 2, 2015 8:00 am
25 views
  • Follow
  • Unfollow
  • Report spam

Meet your next client here. Join our medical devices group community.

Private answer
Ee Bin Liew Thank you, Marcus, for sharing once again. Much appreciated.

Cheers,
Ee Bin
Marked as spam
  • Report spam
Private answer
Karen Boyd, ASQ CQA Likewise, Marcus! Many thanks. :)
Marked as spam
  • Report spam
Private answer
Thobekile Nkala Thanks for sharing Marcus!
Marked as spam
  • Report spam
Private answer
I
Marked as spam
  • Report spam
Private answer
Jenna Groves Great, thanks for the quick links!
Marked as spam
  • Report spam
Private answer
Karthik Venkataraman handy info and links. txs for sharing
Marked as spam
  • Report spam
Private answer
Thanks for sharing!
Marked as spam
  • Report spam
Private answer
Thank you so much for sharing!
Marked as spam
  • Report spam
Private answer
Thanks Marcus I have been searching for an update at least once a month.
Marked as spam
  • Report spam
Private answer
Thank you for sharing, very helpful to try to stay ahead of the change
Marked as spam
  • Report spam
Private answer
Ok Marcus, I liked your comment which is very helpful but forgot to thank you 😁
Many thanks for sharing this info. Regards, MJ
Marked as spam
  • Report spam
Private answer
Bill White The changes will be particularly challenging for IVD companies. An IVD company that waits until the last minute before addressing the changes will be quite sorry.
Marked as spam
  • Report spam
Private answer
Thanks Marcus, your post is really helpful.
Marked as spam
  • Report spam
Private answer
Duncan Dando Marcus,

Much appreciated and well timed as I am just starting to look at this development.

Duncan
Marked as spam
  • Report spam
Private answer
Julie Omohundro I appreciate the links.

I personally try to ignore these legislative/regulatory dramas, which tend to drag on for years. Much of what people talked about and worried about and prepared for will often have changed by the time the drama comes to an end. And long lead times are invariably built into the process for compliance.

I prefer to stay focused on the laws and regulations currently applicable to the work on my desk, and let the drama play out. So I too am...well, still not just starting, but starting to think about how I will start...to look into the revisions, once the process actually comes to an end. I would be interested in attending a conference that covers the revisions in depth. I think this should take at least a full day, could easily run 2-3 days? If anyone has come across, or comes across, this type of opportunity, I (and no doubt others here) would be very interested in hearing about it.
Marked as spam
  • Report spam
Private answer
William (Bill) Jackson Thanks and have not gone through the documents as yet, my weekend reading. I was just on line with the webinar entitled, "The Impact of New CE Marking Rules in Europe", by TUV . I WISH I HAD READ THESE BEFORE THE WEBINAR as the webinar was more the current approach plus at the end the difference proposals from the commission to the presidency. Other thoughts appreciated, keep these documents coming Marcus, kudos to you!!
Marked as spam
  • Report spam
Private answer
Webinar today and these pdfs are quite useful to say the least. Better to have a heads up now than a head knocked later for being 'clueless.'
Marked as spam
  • Report spam
Private answer
Thanks Marcus
Marked as spam
  • Report spam
Private answer
Hi guys
You who are working with regulatory, are you not afraid that the costs for regulatory, in a project, will reach the limit for what a company are prepared to pay for a new product. When I made my first implant in the 1980th I phoned the Swedish authorities on LĂ€kemedelsverket and asked what rules I had to follow, the answer was: Call us back when you are ready and tell us. Of course that is bad, we do need to protect the patient, but when I give a quotation to a customer today for a class III product, the regulatory is about 40% of the total sum. (Plus costs) This is a little scary for me as MedTech development expert. Will the companies go on making new products to benefit patients, especially the small and new once? Will this stop the creativity for new inventive products to reach the market? I think we have a critical balance here, I have had customers saying no thank you depending of those costs. Can we solve this problem, so it benefits all categories involved?
What’s your opinion about this?
Robert
Marked as spam
  • Report spam
Private answer
Marrianne McGhee RN BN MaEd Great share Marcus.
Marked as spam
  • Report spam
Private answer
Robert Axelsson, I just listened to the presentation by Bassil Akra of TUV SUD, and it is seems clear to me that if a company studies the requirements and then the options carefully, that for many products, a less intensive review process might be possible.

If a company properly describes what they are doing which classifies the product as similar to what competitor products exist, then a company can file as an equivalent product with a lower amount of work to do to get clearance.

If the comparison to the 'old' cleared product vs the 'new' product has the "same intended use", "technical equivalence", "biological equivalence", "difference regarding safety" and "difference regarding performance", then the requirements to be met are far lower than if the company submitting for approval claims 'new, unique, etc.'

Obviously a class I or II product will have less stringent needs for consideration.

In the end, a very good analysis of the competitors in the field needs to be undertaken to know whether a new product will face the harsher scrutiny required of a truly unique, cutting edge product.
Marked as spam
  • Report spam
Private answer
Julie Omohundro Robert A, that is a great question, but goes well beyond the scope of this discussion, I think. I dare you to post it as a separate discussion. :) As a starting point, I would love to see a list of what people consider to be "regulatory" and "non-regulatory" costs.

In a mere comment, I will say that, when start-ups come to me and ask about regulatory timeframes and costs, my reply is always, "Trust me, regulatory is the least of your worries." So far, no one has ever looked back and said I was wrong about that. There is nothing much to say about 40% of Class III development cost being "regulatory" costs, without more details.

In the US, "regulatory" costs are the filing fee, plus my time as the regulatory expert. I can't imagine a Class III so simple to develop that the development costs would run a mere 60% of filing fee + my time. Perhaps I should raise my rates. A lot. :)

I have several theories as to why companies think their regulatory costs are so much higher than is at all rational, really. Pursuing this issue is on my to-do list for next year. Will let you know what I find out.

Oh, and to answer your question directly, no, not a bit worried about the regulatory costs. If you are a regulatory professional in the US, it would be a welcome relief to hear various parties here complaining about the high regulatory costs in the EU, rather than the decades-old refrain of "FDA is stifling innovation."
Marked as spam
  • Report spam
Private answer
Julie Omohundro Arithmetically challenged...60% of the total cost, where the filing fee and my time are the other 40%.
Marked as spam
  • Report spam
Private answer
zain malik beacacuse we are working on regulatory in surgical instrument
Marked as spam
  • Report spam
Private answer
zain malik dear robert i m very happy to see here on linkedin if any body work regulatory in any products its regulatory cost 60% to 65% if you are interesting you now about regulatory cost so contact us
feel free at www.punctualsurgical.com
[email protected]
Marked as spam
  • Report spam
Private answer
These are just the Council versions. The European Parliament and the Commission have their own views. The final versions will be compromises between the three sets of views.
Marked as spam
  • Report spam
Private answer
Julie Omohundro Mika, thanks. Are you aware of a website where someone is keeping track of the progress in an easy to check format? I have been looking for one that lists all the steps in the process and then is logging the date of each one as it occurs? The EC's website is not easy to follow, at least not for me. Otherwise, what I find are "timelines," rather than milestone trackers, with more of a focus on predicting the future than tracking progress in real time.
Marked as spam
  • Report spam
« Back to Previous Page

Please log in to post questions.

  • Go to WP login page

Stay connected with us.

By signing up you are agreeing to our Privacy Policy.

Categories

  • Capital/Investment
    • Business Model
    • Funding
  • Careers
  • Design/Devel
    • Design
    • Development
    • Human Factors
    • Labeling
    • Material Selection
    • R&D
    • Trials and Post-Market
  • Featured
  • Industry
    • Announcements
    • Device Tax
    • Hospital and Health Care
    • Innovation
    • Medtech
  • LinkedIn, etc.
  • Markets
    • Africa
    • Americas
    • Asia
    • Australia
    • Europe
  • Regulating
    • CE Marking
    • EU
    • FDA
    • FDA/EU etc.
    • Notified Bodies
    • Quality
    • Regulatory
  • Selling
    • Distribution
    • Intellectual Property
    • Marketing/Sales
    • Reimbursement
  • Worth bookmarking!
Feature your job here.
logo

Companion to LinkedIn's 350,000 member community

  • Contact
  • Medical Device Marketing
  • In Memoriam
  • Medical Device Conference

The Medical Devices Group   |   Copyright © Terms, Conditions & Privacy

Medical Devices Group
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.